50866-30-3

Basic information

• Product Name: 5-methylpyrazine-2-carbaldehyde
• Synonyms: 5-methylpyrazine-2-carbaldehyde;5-Methylpyrazin-2-carboxaldehyde;5-Methyl-2-pyrazinecarboxaldehyde;2-Formyl-5-methylpyrazine;5-Methylpyrazine-2-carboxaldehyde;2-Formyl-5-methylpyrazine, 2-Formyl-5-methyl-1,4-diazine;5-methylpyrazinaldehyde;MFCD10697792
• CAS NO: 50866-30-3
• Molecular Formula: C₆H₆N₂O
• Molecular Weight: 122.13
• Mol File: 50866-30-3.mol
• Article Data: 13

Chemical Properties

• Melting Point: 10-15℃
• Boiling Point: 273℃
• Flash Point: 79℃
• Appearance: /
• Density: 1.176
• Vapor Pressure: 0.265mmHg at 25°C
• Refractive Index: 1.568
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: 0.54±0.10(Predicted)
• CAS DataBase Reference: 5-methylpyrazine-2-carbaldehyde(CAS DataBase Reference)
• NIST Chemistry Reference: 5-methylpyrazine-2-carbaldehyde(50866-30-3)
• EPA Substance Registry System: 5-methylpyrazine-2-carbaldehyde(50866-30-3)

Safety Data

• Hazardous Substances Data: 50866-30-3(Hazardous Substances Data)

Usage

General Description

5-methylpyrazine-2-carbaldehyde is a chemical compound with the molecular formula C7H6N2O. It is a heterocyclic compound that contains a pyrazine ring with a methyl group and an aldehyde functional group. 5-methylpyrazine-2-carbaldehyde is commonly used as a flavoring agent in food and beverages due to its nutty and roasted aroma. It is also used in the production of various fragrance and perfume products. In addition, 5-methylpyrazine-2-carbaldehyde has been studied for its potential pharmaceutical applications, particularly in the development of new drugs with anti-inflammatory and antioxidant properties. However, it is important to handle this chemical with caution as it may be harmful if ingested or inhaled and can cause skin and eye irritation.

InChI:InChI=1/C6H6N2O/c1-5-2-8-6(4-9)3-7-5/h2-4H,1H3

Upstream product

• 123-32-0 2,5-dimethyl-pyrazine 
• 41110-33-2 5-methylpyrazine-2-carboxylic acid methyl ester 
• 5521-55-1 2-methylpyrazin-5-carboxylic acid 

Downstream Products

• 923206-05-7 5-methyl-N-phenylpyrazine-2-carboxamide 
• 1176953-20-0 C₂₀H₁₆N₄O₂ 

Relevant articles and documents

ISOXAZOLIDINES AS RIPK1 INHIBITORS AND USE THEREOF

The present invention relates to isoxazolidines of formula I and their use as receptor-interacting protein kinase 1 inhibitors, for example in the treatment of diseases and disorders mediated by RIP kinase (1) such as rheumatoid arthritis (RA), psoriasis, inflammatory bowel disease (IBD), Crohn's disease or ulcerative colitis.

HETEROARYL-SUBSTITUTED TRIAZOLES AS APJ RECEPTOR AGONISTS

Compounds of Formula (I) and Formula (II), pharmaceutically acceptable salt thereof, stereoisomers of any of the foregoing, or mixtures thereof are agonists of the APJ Receptor and may have use in treating cardiovascular and other conditions. Compounds of Formula I and Formula II have the following structures: where the definitions of the variables are provided herein.

TRIAZOLE PHENYL COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR

Compounds of Formula I and Formula II, pharmaceutically acceptable salt thereof, stereoisomers of any of the foregoing, or mixtures thereof are agonists of the APJ Receptor and may have use in treating cardiovascular and other conditions. Compounds of Formula I and Formula II have the following structures: (I), (II) where the definitions of the variables are provided herein.